OTCMKTS:STDAF STADA Arzneimittel Aktiengesellschaft (STDAF) Stock Price, News & Analysis → Crypto Market Preps For Trillions Worth of Inflows! (From Crypto 101 Media) (Ad) Free STDAF Stock Alerts $110.42 0.00 (0.00%) (As of 10/24/2022) Add Compare Share Share Today's Range$110.42▼$110.4250-Day Range$110.42▼$110.4252-Week Range$75.15▼$115.00VolumeN/AAverage Volume180 shsMarket Capitalization$6.88 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get STADA Arzneimittel Aktiengesellschaft alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About STADA Arzneimittel Aktiengesellschaft Stock (OTCMKTS:STDAF)STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Read More STDAF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STDAF Stock News HeadlinesFebruary 22, 2024 | washingtonpost.comSTAFF NEWSJanuary 10, 2024 | seekingalpha.comKPLUY K+S AktiengesellschaftMarch 28, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…January 10, 2024 | seekingalpha.comKPLUY K+S AktiengesellschaftJuly 21, 2023 | investing.comSTADA Arzneimittel AG V (SAZA)May 30, 2023 | bbc.co.ukCBI hired 'toxic' staff and failed to sack offendersJanuary 28, 2023 | seekingalpha.comSartorius Aktiengesellschaft 2022 Q4 - Results - Earnings Call PresentationSee More Headlines Receive STDAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STADA Arzneimittel Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:STDAF Previous SymbolNASDAQ:STDAF CUSIPN/A CIKN/A Webwww.stada.com Phone(496) 101-6030Fax49-61-0160-3259Employees12,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.23 Current Ratio1.54 Quick Ratio0.99 Sales & Book Value Annual Sales$3.84 billion Price / Sales1.79 Cash Flow$11.12 per share Price / Cash Flow9.93 Book Value$23.11 per share Price / Book4.78Miscellaneous Outstanding Shares62,342,000Free FloatN/AMarket Cap$6.88 billion OptionableNot Optionable Beta0.38 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesPeter GoldschmidtChairman-Executive BoardWolfgang OlligChief Financial OfficerMiguel Pagan FernandezChief Technical OfficerYann BrunEVP, Head-Regulatory & Business DevelopmentFrank SeilerHead-Investor Relations ContactKey CompetitorsGlobus MedicalNYSE:GMEDSino BiopharmaceuticalOTCMKTS:SBMFFViking TherapeuticsNASDAQ:VKTXHealthEquityNASDAQ:HQYDENTSPLY SIRONANASDAQ:XRAYView All Competitors STDAF Stock Analysis - Frequently Asked Questions How have STDAF shares performed in 2024? STADA Arzneimittel Aktiengesellschaft's stock was trading at $110.42 at the beginning of 2024. Since then, STDAF shares have increased by 0.0% and is now trading at $110.42. View the best growth stocks for 2024 here. How do I buy shares of STADA Arzneimittel Aktiengesellschaft? Shares of STDAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:STDAF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STADA Arzneimittel Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.